Characterize the news's sentiment using the following options.
Options: negative, positive

AbbVie will be releasing Phase 2 data for its experimental Cystic Fibrosis (CF) drugs that could potentially compete with Vertex's drugs. VRTX stock may move up or down, inversely related to the AbbVie data set.
negative